Thomas Pabst Selected Research

Thomas Pabst Research Topics

Disease

62	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 09/2004
34	Neoplasms (Cancer) 01/2024 - 01/2010
20	Leukemia 04/2024 - 09/2004
17	Multiple Myeloma 03/2024 - 07/2015
13	Lymphoma (Lymphomas) 12/2023 - 10/2014
12	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 08/2005
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2024 - 06/2015
5	Residual Neoplasm 12/2023 - 11/2017
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2023 - 09/2016
5	B-Cell Lymphoma (Lymphoma, B Cell) 03/2023 - 01/2016
4	Cytokine Release Syndrome 01/2023 - 01/2020
4	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 09/2015
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 09/2013
4	Body Weight (Weight, Body) 01/2019 - 08/2006
3	cell-associated neurotoxicity 03/2023 - 01/2023
3	Acute Promyelocytic Leukemia 12/2018 - 04/2006
2	COVID-19 11/2023 - 07/2022
2	Stroke (Strokes) 11/2023 - 01/2023
2	Infections 12/2022 - 11/2017
2	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2022 - 03/2015
2	Disease Progression 01/2022 - 02/2016
2	Human Influenza (Influenza) 01/2022 - 01/2021
2	Amyloidosis 10/2021 - 11/2020
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2021 - 01/2018
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2020 - 02/2016
2	Bacteremia 12/2020 - 11/2017
2	Immunoglobulin Light-chain Amyloidosis 11/2020 - 02/2014
2	Hemorrhage 01/2020 - 08/2006
2	Myeloid Leukemia (Leukemia, Myelocytic) 11/2019 - 04/2008
2	Neutropenia 01/2019 - 11/2017
2	GATA2 Deficiency 10/2018 - 01/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2017 - 09/2004
2	Pathologic Complete Response 01/2017 - 01/2014
2	Polyneuropathies (Polyneuropathy) 05/2016 - 07/2015

Drug/Important Bio-Agent (IBA)

13	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2020
11	Melphalan (Alkeran)FDA LinkGeneric 01/2024 - 10/2014
11	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2023 - 02/2008
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 01/2013
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2014
7	Transcription Factors (Transcription Factor)IBA 01/2020 - 09/2004
6	Bortezomib (Velcade)FDA Link 01/2024 - 07/2015
6	Etoposide (VP 16)FDA LinkGeneric 12/2023 - 01/2013
5	Bendamustine Hydrochloride FDA Link 12/2023 - 01/2016
5	Rituximab (Mabthera)FDA Link 12/2020 - 08/2015
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2004
4	Busulfan (Busulfex)FDA Link 11/2023 - 01/2017
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 06/2012
4	Bleomycin (Blenoxane)FDA LinkGeneric 06/2021 - 01/2013
4	Lenalidomide (CC 5013)FDA Link 05/2021 - 01/2016
3	Apoptosis Regulatory ProteinsIBA 03/2024 - 10/2022
3	Messenger RNA (mRNA)IBA 11/2023 - 09/2004
3	S63845IBA 07/2021 - 11/2019
3	Vincristine (Oncovin)FDA LinkGeneric 06/2021 - 01/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2021 - 01/2013
3	Prednisone (Sone)FDA LinkGeneric 06/2021 - 01/2013
3	Procarbazine (Matulane)FDA Link 06/2021 - 01/2013
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2018 - 04/2006
3	CCAAT-Enhancer-Binding Protein-alphaIBA 04/2008 - 02/2005
2	Bispecific AntibodiesIBA 03/2024 - 01/2022
2	Carmustine (FIVB)FDA Link 12/2023 - 03/2017
2	mRNA VaccinesIBA 11/2023 - 07/2022
2	Azacitidine (5 Azacytidine)FDA Link 07/2023 - 01/2014
2	Monoclonal AntibodiesIBA 07/2023 - 09/2013
2	midostaurinIBA 01/2023 - 11/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 02/2021
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2023 - 01/2017
2	fibrin fragment D (D-dimer)IBA 01/2023 - 08/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 11/2018
2	Clofarabine (Clolar)FDA Link 01/2022 - 03/2017
2	Prealbumin (Transthyretin)IBA 10/2021 - 11/2020
2	fms-Like Tyrosine Kinase 3IBA 07/2021 - 02/2005
2	trametinibIBA 02/2021 - 11/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2021 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2016
2	Cladribine FDA LinkGeneric 11/2020 - 01/2017
2	Fibrinogen (Factor I)FDA Link 01/2020 - 12/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 11/2017
2	Nelfinavir (Viracept)FDA Link 11/2018 - 03/2016
2	Proteasome InhibitorsIBA 11/2018 - 03/2016
2	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 01/2018
2	ibritumomab tiuxetan (Zevalin)FDA Link 12/2017 - 09/2016
2	LipidsIBA 06/2017 - 11/2011
2	Vinorelbine (Navelbine)FDA LinkGeneric 05/2016 - 07/2015
2	AnthracyclinesIBA 01/2016 - 02/2008
2	CCAAT-Enhancer-Binding ProteinsIBA 01/2016 - 05/2011

Therapy/Procedure

41	Therapeutics 03/2024 - 09/2004
39	Drug Therapy (Chemotherapy) 12/2023 - 02/2008
31	Stem Cell Transplantation 12/2023 - 01/2013
9	Hematopoietic Stem Cell Transplantation 04/2024 - 06/2012
7	Autologous Transplantation 09/2022 - 10/2014
5	Induction Chemotherapy 04/2024 - 04/2010
4	Radiotherapy 10/2023 - 09/2010
4	Hematopoietic Stem Cell Mobilization 01/2023 - 10/2018
3	Thrombectomy 11/2023 - 01/2022
3	Homologous Transplantation 10/2023 - 01/2017
3	Transplantation 08/2021 - 01/2017
3	Blood Component Removal (Apheresis) 01/2019 - 08/2006
2	Cell Transplantation 10/2018 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 12/2017 - 03/2015